Koers Aurora Cannabis Inc Other OTC
Aandelen
CA05156X1087
Farmaceutische producten
Omzet 2025 * | 302 mln. 221 mln. 207 mln. | Omzet 2026 * | 350 mln. 256 mln. 239 mln. | Marktkapitalisatie | 352 mln. 258 mln. 241 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2025 * | -19 mln. -13,91 mln. -12,99 mln. | Nettowinst (verlies) 2026 * | -1 mln. -732K -683K | EV/omzet 2025 * | 1,17 x |
Nettoliquiditeiten 2025 * | - 0 0 | Nettoliquiditeiten 2026 * | - 0 0 | EV/omzet 2026 * | 1,01 x |
K/w-verhouding 2025 * |
-15,8
x | K/w-verhouding 2026 * |
-152
x | Werknemers | - |
Dividendrendement 2025 * |
-
| Dividendrendement 2026 * |
-
| Vrij verhandelbaar | 99,99% |
Recentste transcriptie over Aurora Cannabis Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Miguel Martin
CEO | Chief Executive Officer | 52 | 06-07-20 |
Simona King
DFI | Director of Finance/CFO | 52 | 21/02 |
Dave Aird
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ronald Funk
CHM | Chairman | 67 | 25-07-18 |
Director/Board Member | - | 15/05 | |
Michael Singer
BRD | Director/Board Member | 60 | 20-05-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,76% | 5,68 mld. | |
-32,34% | 3,59 mld. | |
-2,23% | 3,12 mld. | |
-25,26% | 2,62 mld. | |
-10,88% | 2,3 mld. | |
+40,09% | 1,88 mld. | |
+40,90% | 1,45 mld. | |
-15,16% | 1,39 mld. | |
+42,86% | 1,37 mld. |